Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Brown vs TPL

There had been an order re: alter ego and the judgment was against Brown. His attorney filed the following:

Cv Ntc:Motion W/Fee 1/11/2013 (To vacate jgmt)

For: Chester A. Brown / PLX
For: Marcie Brown / PLX

Cv Ntc:Intent/Move For New Trial 01/11/2013

For: Chester A. Brown / PLX
For: Marcie Brown / PLX

Don't forget that the orginal master agreement between PTSC and TPL states that BK would void the agreement. Very slick maneuver by PTSC and TPL in their recent restructing agreement to transfer the commercialization of the MMP out of TPL's control. I'm not an attorney and perhaps Ron might offer some insight here. If TPL is no longer licensing the MMP and Brown's agreement is with TPL, then if TPL files BK it can't pay the $8million. However, if there is a new trial for Brown, regarding the alter ego argument, and if Brown wins, then Leckrone's money (wherever it may be) could be used to pay Brown. How this may effect Moore I don't know. Perhaps the patent ownership litigation between Moore and TPL may in fact be fast approaching a settlement. It will be interesting to see what is announced in the proxy and/or at the ASHM.

Share
New Message
Please login to post a reply